THE UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced it has improved the functionality of its Yellow Card Scheme for reporting adverse drug reactions (ADRs).
A pilot program to test new Ulysses risk management software is being conducted with the Nottinghamshire Healthcare NHS Foundation Trust, which has nearly 200 healthcare sites.
Previous enhancements which saw the Yellow Card Scheme reporting functionality included in clinical systems has ramped up ADR reporting levels, alerting the MHRA to early signs of possible drug safety issues.
MHRA Head of Pharmacovigilance Strategy Mick Foy said the upgrade of the platform was a great step forward for patient safety.
"A good reporting culture is a sign of good patient safety practice within an organisation and we hope the pilot will encourage other healthcare providers to use our Yellow Card Scheme and contribute to improved UK drug safety monitoring," Foy said.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Oct 18
